密歇根医疗补助计划中青少年特发性关节炎患儿的处方模式：按开处方者类型进行的比较
Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type.
作者信息
Riebschleger Meredith P, Van Mater Heather A, Cohn Lisa M, Clark Sarah J
机构信息
Division of Pediatric Rheumatology, Child Health Evaluation and Research Unit, University of Michigan, 6C15A NIB, 300 North Ingalls, Ann Arbor, MI 48109 USA.
Division of Pediatric Rheumatology, Duke University, Durham, NC USA.
出版信息
Pediatr Rheumatol Online J. 2014 Sep 5;12:38. doi: 10.1186/1546-0096-12-38. eCollection 2014.
BACKGROUND
Due to a limited number and disparate distribution of pediatric rheumatologists in the US, a variety of physician types provide care to children with rheumatologic diseases. However, little is known about how that care may differ across prescribing physician groups. Our objective was to compare medication claims for children with juvenile idiopathic arthritis (JIA) by type of prescribing physician.
METHODS
We performed a retrospective cohort study of children with JIA using Michigan Medicaid data for 7/1/2005-6/30/2007, employing descriptive and bivariate analyses by age, medication type, and prescriber type.
RESULTS
Among 397 children, there was no difference in the frequency of medication claims for children with internist versus pediatric rheumatologist prescribers. Children with non-rheumatologist prescribers were less likely to have claims for disease modifying anti-rheumatic drugs (DMARDs) and biologic agents.
CONCLUSION
Differential use of DMARDs and biologic agents by rheumatologists indicates the importance of referring children with JIA for specialty care.
背景
由于美国儿科风湿病专家数量有限且分布不均，各类医生都为患有风湿性疾病的儿童提供治疗。然而，对于不同处方医生群体所提供的治疗可能存在的差异知之甚少。我们的目的是比较不同类型处方医生为幼年特发性关节炎（JIA）患儿开具药物的情况。
方法
我们利用密歇根医疗补助数据对2005年7月1日至2007年6月30日期间的JIA患儿进行了一项回顾性队列研究，按年龄、药物类型和处方医生类型进行描述性和双变量分析。
结果
在397名儿童中，内科医生处方与儿科风湿病专家处方的患儿用药申请频率没有差异。非风湿病专家处方的患儿开具改善病情抗风湿药物（DMARDs）和生物制剂的申请可能性较小。
结论
风湿病专家对DMARDs和生物制剂的使用差异表明，将JIA患儿转诊至专科治疗具有重要意义。
Zotero 插件